ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook
ADMA Biologics(US:ADMA) ZACKS·2026-01-13 19:31Key Takeaways ADMA expects ~$510$511M in 2025 revenues and ended the year with about $88M in cash.ADMA lifted 2026 revenue guidance to ~$635M and raised EBITDA outlook on yield-enhanced production.ADMA sees accelerating Asceniv demand, broader plasma access, and margin expansion driving growth into 2027.ADMA Biologics, Inc. (ADMA) announced preliminary unaudited full-year 2025 revenue numbers and provided a business update.The company estimates total revenues of approximately $510-$511 million for 2025. ADM ...